Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Aug;57(4):495–500. doi: 10.1111/j.1476-5381.1976.tb10376.x

Dual effects of aspirin in guinea-pig lungs.

E Mielens, F J Rosenberg
PMCID: PMC1667042  PMID: 963338

Abstract

Dual effects of aspirin were demonstrated in guinea-pig lungs: (a) aspirin (3.3 mg/kg i.v.) antagonized bronchoconstriction induced by slow reacting substance of anaphylaxis (SRS-A); (b) aspirin produced bronchoconstriction when injected in the presence of propranolol into guinea-pigs in vivo at 330 mg/kg, or into guinea-pig isolated lungs in vitro as a 4% solution (40 mg/ml). 2 The severity of bronchoconstriction following administration of aspirin was directly related to the degree of beta-adrenoceptor blockade and to the age of the guinea-pigs. Aspirin-induced bronchoconstriction was prevented in vivo and in vitro by atropine and it could be reversed in vivo by atropine. Aspirin-induced bronchoconstriction was not inhibited by vagotomy or phenoxybenzamine. 3 These data suggest that the mechanism involved in aspirin-induced bronchoconstriction may be local cholinergic stimulation and that reduced beta-adrenergic drive may be a predisposing factor.

Full text

PDF
495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERRY P. A., COLLIER H. O. BRONCHOCONSTRICTOR ACTION AND ANTAGONISM OF A SLOW-REACTING SUBSTANCE FROM ANAPHYLAXIS OF GUINEA-PIG ISOLATED LUNG. Br J Pharmacol Chemother. 1964 Aug;23:201–216. doi: 10.1111/j.1476-5381.1964.tb01579.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collier H. O., James G. W., Piper P. J. Antagonism by fenamates and like-acting drugs of bronchoconstriction induced by bradykinin or antigen in the guinea-pig. Br J Pharmacol. 1968 Sep;34(1):76–87. doi: 10.1111/j.1476-5381.1968.tb07952.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Weck A. L. Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. Int Arch Allergy Appl Immunol. 1971;41(2):393–418. doi: 10.1159/000230534. [DOI] [PubMed] [Google Scholar]
  4. Delaney J. C. Letter: Inhibition of prostaglandin biosynthesis by analgesics in relation to asthma. Br Med J. 1975 Mar 1;1(5956):516–516. doi: 10.1136/bmj.1.5956.516-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Delaney J. C., Smith J. B., Silver M. J. Prostaglandin levels in blood plasma during asthmatic attacks in patients with aspirin idiosyncrasy. Postgrad Med J. 1975 Jan;51(591):15–17. doi: 10.1136/pgmj.51.591.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Falliers C. J. Aspirin and subtypes of asthma: risk factor analysis. J Allergy Clin Immunol. 1973 Sep;52(3):141–147. doi: 10.1016/0091-6749(73)90030-4. [DOI] [PubMed] [Google Scholar]
  7. Farr R. S. Presidential message. The need to re-evaluate acetylsalicylic acid (aspirin). J Allergy. 1970 Jun;45(6):321–328. doi: 10.1016/0021-8707(70)90040-7. [DOI] [PubMed] [Google Scholar]
  8. Fisherman E. W., Cohen G. N. Cholinergic and adrenergic stimulation correlated with aspirin intolerance (hypersensitivity). Ann Allergy. 1974 Oct;33(4):209–218. [PubMed] [Google Scholar]
  9. Giraldo B., Blumenthal M. N., Spink W. W. Aspirin intolerance and asthma. A clinical and immunological study. Ann Intern Med. 1969 Sep;71(3):479–496. doi: 10.7326/0003-4819-71-3-479. [DOI] [PubMed] [Google Scholar]
  10. LABORIE R. SUR L'ACTION BIOLOGIQUE DE L'ACIDE AC'ETYL SALICYLIQUE (ASPIRINE) DANS LE TRAITEMENT DE L'ASTHME ALLERGIQUE. Toulouse Med. 1964 Aug-Sep;65:903–921. [PubMed] [Google Scholar]
  11. LUDUENA F. P., MILLER E., WILT W. A. A new perfusion apparatus for the study of the effects of drugs on the coronary vessels. J Am Pharm Assoc Am Pharm Assoc. 1955 Jun;44(6):363–366. doi: 10.1002/jps.3030440617. [DOI] [PubMed] [Google Scholar]
  12. Orange R. P., Austen K. F. Pharmacologic dissociation of immunologic release of histamine and slow reacting substance of anaphylaxis in rats. Proc Soc Exp Biol Med. 1968 Dec;129(3):836–841. doi: 10.3181/00379727-129-33437. [DOI] [PubMed] [Google Scholar]
  14. STRESEMANN E. DIE WIRKUNG VON ANTIPYRETISCHEN UND ANALGETISCHEN SUBSTANZEN AUF DAS MENSCHLICHE BRONCHIALASTHMA UND DAS EXPERIMENTELLE MEERSCHWEINCHENASTHMA. Acta Allergol. 1963;18:211–234. [PubMed] [Google Scholar]
  15. Samter M., Beers R. F., Jr Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968 May;68(5):975–983. doi: 10.7326/0003-4819-68-5-975. [DOI] [PubMed] [Google Scholar]
  16. Schlumberger H. D., Löbbecke E. A., Kallós P. Acetylsalicylic acid intolerance. Acta Med Scand. 1974 Dec;196(6):451–458. doi: 10.1111/j.0954-6820.1974.tb01040.x. [DOI] [PubMed] [Google Scholar]
  17. Smith A. P. Response of aspirin-allergic patients to challenge by some analgesics in common use. Br Med J. 1971 May 29;2(5760):494–496. doi: 10.1136/bmj.2.5760.494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Szczeklik A., Gryglewski R. J., Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J. 1975 Jan 11;1(5949):67–69. doi: 10.1136/bmj.1.5949.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Yurchak A. M., Wicher K., Arbesman C. E. Immunologic studies on aspirin. Clinical studies with aspiryl-protein conjugates. J Allergy. 1970 Oct;46(4):245–253. doi: 10.1016/0021-8707(70)90028-6. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES